Comment Regarding Increased Striatal Glutamate in Schizophrenia
- 13 February 2012
- journal article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 37 (4), 1067-1068
- https://doi.org/10.1038/npp.2011.180
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Relationship between non-alcoholic fatty liver disease and kidney function: A communication between two organs that needs further explorationArab Journal of Gastroenterology, 2012
- Nonalcoholic steatohepatitis and increased risk of chronic kidney diseaseMetabolism, 2011
- Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode PsychosisNeuropsychopharmacology, 2011
- Systematic review: the diagnosis and staging of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitisAlimentary Pharmacology & Therapeutics, 2010
- Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic SteatohepatitisClinical Journal of the American Society of Nephrology, 2010
- Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001–2006Nutrition, Metabolism and Cardiovascular Diseases, 2010
- Noninvasive assessment of liver fibrosisHepatology, 2010
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connectionHepatology, 2010
- Non-alcoholic fatty liver disease and increased risk of cardiovascular diseaseAtherosclerosis, 2007
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993